MedTrace Logo

Prognostic Value of Vitamin D and Intact Parathyroid Hormone (iPTH) in Pulmonary Hypertension

NCT06872710 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 345

Last updated 2025-03-12

No results posted yet for this study

Summary

The aim of this observational study is to analyse the prognostic value of 25(OH)-vitamin D, iPTH and other serum biomarkers in patients with pulmonary hypertension.

Serum samples are obtained from the Spanish Biobank of pulmonary hypertension. Clinical data will be collected from the Spanish registries on pulmonary hypertension (REHAP and REHAR).

Conditions

  • Pulmonary Hypertension

Interventions

OTHER

There are no interventions. Samples were collected by the Biobank since 2013.

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Universidad Complutense de Madrid

    lead OTHER

Principal Investigators

  • Francisco Perez Vizcaino, PhD · Universidad Complutense de Madrid

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-07-01
Completion
2025-12-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06872710 on ClinicalTrials.gov